Alnylam Pharmaceuticals | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Takeda JPY 699.51B 38B 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Alnylam Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.